Assessing the benefits and harms of direct oral anticoagulants in patients with cancer for the prophylaxis and treatment of venous thromboembolism: a systematic review and meta-analysis

BACKGROUND: Direct oral anticoagulants (DOACs) have recently been tested in multiple randomised controlled trials (RCTs) for the prophylaxis and treatment of cancer-associated venous thromboembolism (VTE) leading to changes in guidelines. To quantify the risks and benefits of DOACs in the prophylaxi...

Descripción completa

Detalles Bibliográficos
Autores principales: Desai, Aakash, Gyawali, Bishal
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cancer Intelligence 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7498277/
https://www.ncbi.nlm.nih.gov/pubmed/33014133
http://dx.doi.org/10.3332/ecancer.2020.1091

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7498277/
https://www.ncbi.nlm.nih.gov/pubmed/33014133
http://dx.doi.org/10.3332/ecancer.2020.1091

Ejemplares similares